rs16887018

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_007175.8(ERLIN2):​c.318C>T​(p.Asn106Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00465 in 1,614,062 control chromosomes in the GnomAD database, including 270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 138 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 132 hom. )

Consequence

ERLIN2
NM_007175.8 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.37

Publications

3 publications found
Variant links:
Genes affected
ERLIN2 (HGNC:1356): (ER lipid raft associated 2) This gene encodes a member of the SPFH domain-containing family of lipid raft-associated proteins. The encoded protein is localized to lipid rafts of the endoplasmic reticulum and plays a critical role in inositol 1,4,5-trisphosphate (IP3) signaling by mediating ER-associated degradation of activated IP3 receptors. Mutations in this gene are a cause of spastic paraplegia-18 (SPG18). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]
ERLIN2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 18
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • juvenile primary lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 8-37744590-C-T is Benign according to our data. Variant chr8-37744590-C-T is described in ClinVar as Benign. ClinVar VariationId is 129021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.37 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0788 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERLIN2NM_007175.8 linkc.318C>T p.Asn106Asn synonymous_variant Exon 6 of 12 ENST00000519638.3 NP_009106.1 O94905-1A0A384ME54

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERLIN2ENST00000519638.3 linkc.318C>T p.Asn106Asn synonymous_variant Exon 6 of 12 2 NM_007175.8 ENSP00000428112.1 O94905-1

Frequencies

GnomAD3 genomes
AF:
0.0235
AC:
3576
AN:
152116
Hom.:
138
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0813
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00721
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.00630
AC:
1585
AN:
251446
AF XY:
0.00473
show subpopulations
Gnomad AFR exome
AF:
0.0811
Gnomad AMR exome
AF:
0.00431
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000721
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00269
AC:
3933
AN:
1461828
Hom.:
132
Cov.:
31
AF XY:
0.00240
AC XY:
1742
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0838
AC:
2805
AN:
33472
American (AMR)
AF:
0.00487
AC:
218
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000441
AC:
38
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5766
European-Non Finnish (NFE)
AF:
0.000468
AC:
520
AN:
1111964
Other (OTH)
AF:
0.00518
AC:
313
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
238
476
714
952
1190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0235
AC:
3577
AN:
152234
Hom.:
138
Cov.:
32
AF XY:
0.0221
AC XY:
1646
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0811
AC:
3366
AN:
41506
American (AMR)
AF:
0.00720
AC:
110
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68032
Other (OTH)
AF:
0.0166
AC:
35
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
163
325
488
650
813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0131
Hom.:
51
Bravo
AF:
0.0264
Asia WGS
AF:
0.00260
AC:
10
AN:
3478
EpiCase
AF:
0.00147
EpiControl
AF:
0.00124

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Spastic paraplegia Benign:1
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Oct 05, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
9.2
DANN
Benign
0.80
PhyloP100
3.4
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16887018; hg19: chr8-37602108; API